CellSource raised its earnings forecast for the fiscal year ending October 2026, improving operating profit/loss from a ¥221 million loss to a ¥82 million profit. As of the end of the third quarter, sales, led by contract processing services, have been trending above the initial forecast.
CellSource raised its earnings forecast for the fiscal year ending October 2026, lifting operating profit/loss from a ¥221 million loss to a ¥82 million profit.
As of the third quarter, sales centered on contract processing services have been trending above the initial forecast.
One factor behind the upward revision was the company’s progress in focusing on selected businesses.